302 related articles for article (PubMed ID: 7043266)
41. Adjuvant chemotherapy for breast cancer.
Holland JF
Surg Clin North Am; 1981 Dec; 61(6):1361-70. PubMed ID: 6797078
[No Abstract] [Full Text] [Related]
42. Perioperative and conventionally timed chemotherapy in operable breast cancer.
Goldhirsch A
Recent Results Cancer Res; 1985; 98():106-13. PubMed ID: 3839931
[No Abstract] [Full Text] [Related]
43. The medical management of breast cancer.
Costanza ME
Clin Obstet Gynecol; 1982 Jun; 25(2):433-41. PubMed ID: 7105517
[No Abstract] [Full Text] [Related]
44. Combined chemo- and hormonal therapy in advanced breast cancer.
Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
[No Abstract] [Full Text] [Related]
45. On the safety of perioperative adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in breast cancer.
Ludwig Breast Cancer Study Group
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1305-8. PubMed ID: 2903057
[TBL] [Abstract][Full Text] [Related]
46. Multimodal therapy in the treatment of breast cancer.
Levitt SH; Khan FM; Boen JR; Potish RA; Bowers BJ
Am J Clin Oncol; 1983 Aug; 6(4):387-91. PubMed ID: 6688149
[No Abstract] [Full Text] [Related]
47. The relation between sex hormone binding globulin and response to cytotoxic chemotherapy (CAF therapy) in breast cancer.
Murayama Y; Nagashima M; Aoyagi K; Asano K
Nihon Gan Chiryo Gakkai Shi; 1980 Jun; 15(3):334-8. PubMed ID: 7190994
[No Abstract] [Full Text] [Related]
48. Castration induced by cytotoxic chemotherapy.
Brincker H; Mouridsen HT; Andersen KW; Rose C; Dombernowsky P
J Clin Oncol; 1989 May; 7(5):679-80. PubMed ID: 2651582
[No Abstract] [Full Text] [Related]
49. [Chemotherapic management of genitomammary tumors].
Sarría JA; Irigoyen ML; Cismondi B
Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
[No Abstract] [Full Text] [Related]
50. Chemotherapy of breast cancer. A general overview.
Henderson IC
Cancer; 1983 Jun; 51(12 Suppl):2553-9. PubMed ID: 6189577
[TBL] [Abstract][Full Text] [Related]
51. Dose intensity in chemotherapy of metastatic breast cancer.
J Clin Oncol; 1985 Jun; 3(6):889-91. PubMed ID: 3891924
[No Abstract] [Full Text] [Related]
52. Preoperative adjuvant chemotherapy (neoadjuvant) for carcinoma of the breast: rationale and safety report.
Ragaz J; Baird R; Rebbeck P; Goldie A; Coldman A; Spinelli J
Recent Results Cancer Res; 1985; 98():99-105. PubMed ID: 3839932
[No Abstract] [Full Text] [Related]
53. Critical review of adjuvant therapy in premenopausal patients.
Mouridsen HT
Recent Results Cancer Res; 1989; 115():132-5. PubMed ID: 2623330
[No Abstract] [Full Text] [Related]
54. Systemic therapy for micrometastatic breast cancer.
Lindgren T; Haskell CM
Cancer Invest; 1987; 5(3):205-13. PubMed ID: 2443225
[No Abstract] [Full Text] [Related]
55. Adjuvant therapy of stage II, III breast cancer.
Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
[No Abstract] [Full Text] [Related]
56. Patterns of metastasis and natural courses of breast carcinoma.
Lee YT
Cancer Metastasis Rev; 1985; 4(2):153-72. PubMed ID: 3893684
[TBL] [Abstract][Full Text] [Related]
57. Favorable factors in the adjuvant therapy of breast cancer.
Carpenter JT; Maddox WA; Laws HL; Wirtschafter DD; Soong SJ
Cancer; 1982 Jul; 50(1):18-23. PubMed ID: 7044517
[TBL] [Abstract][Full Text] [Related]
58. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer.
Boyages J; Recht A; Connolly J; Schnitt S; Rose MA; Silver B; Harris JR
Recent Results Cancer Res; 1989; 115():92-102. PubMed ID: 2623339
[No Abstract] [Full Text] [Related]
59. Chemotherapy of breast cancer: current views and results.
Bonadonna G; Valagussa P
Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):279-97. PubMed ID: 6341335
[TBL] [Abstract][Full Text] [Related]
60. Currently active protocols in the EORTC Breast Cancer Cooperative Group.
Mouridsen HT; Palshof T; Mattheiem W; Sylvester RJ; Rotmensz N; Paridaens RJ
Recent Results Cancer Res; 1984; 91():263-7. PubMed ID: 6374800
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
